Trend Future Income
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Trend Future Income

Investing

Maiden Drill Program Commences at Oasis Uranium Project

by admin July 28, 2025
July 28, 2025
Maiden Drill Program Commences at Oasis Uranium Project

Greenvale Energy (GRV:AU) has announced Maiden Drill Program Commences at Oasis Uranium Project

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Completion of Silver Acquisition & Appointment of New Managing Director
next post
RAD receives IND approval from US FDA for Betabart (RV-01)

You may also like

Editor’s Picks: Miners Rescued, US Mine Waste Strategy,...

Mali Court Upholds Detention of Barrick Employees

Trump and Vietnam Strike Tariff Deal, Last-Minute Agreement...

Grande Portage Closes Non-Brokered Private Placement Pursuant to...

CuFe Limited

Broad gold intercepts in Sandstone drilling

Harvest Gold Identifies 15 Primary And 10 Secondary...

Crypto Market Recap: Crypto’s Serenity Amidst Conflict, Exchange...

White House Unveils 90-Point AI Strategy

Alvopetro Announces May 2025 Sales Volumes and an...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating...

    • Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

    • Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval

    • Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility

    • Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart

    Categories

    • Business (70)
    • Investing (522)
    • Politics (701)
    • World (263)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Disclaimer: trendfutureincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 trendfutureincome.com | All Rights Reserved


    Back To Top